TAT GIDA SANAYİ A.Ş.

Share Issue/Capital Change • Apr 10, 2025

Summary Info	General assembly approval for the extension of the validity period and the increase of the upper limit of the Company's authorized capital
Update Notification Flag	Yes
Correction Notification Flag	No
Postponed Notification Flag	No

Board Decision Date	20.02.2025
Related Authorized Capital Process	Increase Of Authorized Capital
Current Authorized Capital (TL)	250.000.000
New Authorized Capital (TL)	2.000.000.000
Due Date For The Authorized Capital (New)	31.12.2029
Number Of Articles Of Association Item To Be Amended	6
Capital Market Board Application Date	20.02.2025
Capital Market Board Application Result	APPROVAL
Capital Market Board Approval Date	27.02.2025
Date of Related General Assembly	09.04.2025
Was The Issue Of Authorized Capital Negotiated? Was It Accepted?	Accepted

Additional Explanations

The amendment proposal to the Company's articles of association on the extension of the validity period of the authorized capital until the end of 2029 and the increase of its upper limit to TRY 2,000,000,000, which was previously approved by the Capital Markets Board and the Ministry of Trade, has been approved by the general assembly.

This statement has been translated into English for informational purposes. In case of a discrepancy between the Turkish and the English versions of this disclosure, the Turkish version shall prevail.

Supplementary Documents

Appendix: 1	TADİL TASARISI.pdf
Appendix: 2	AMENDMENT TEXT.pdf